About: Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community
Creator	Huang, Wei Li, Xiaosong Liu, Kai Chan, Goh, Yi Liu, Xiaogang Luo, Zichao Tao, Jun Yan, Shuangqian Yi, Zhigao Zhang, Hongjie Ang, Yan Jin, Melgious Siew, Yin
Source	Medline; PMC
abstract	The World Health Organization (WHO) has declared the outbreak of 2019 novel coronavirus, known as 2019-nCoV, a pandemic, as the coronavirus has now infected over 2.6 million people globally and caused more than 185,000 fatalities as of April 23, 2020. Coronavirus disease 2019 (COVID-19) causes a respiratory illness with symptoms such as dry cough, fever, sudden loss of smell, and, in more severe cases, difficulty breathing. To date, there is no specific vaccine or treatment proven effective against this viral disease. Early and accurate diagnosis of COVID-19 is thus critical to curbing its spread and improving health outcomes. Reverse transcription-polymerase chain reaction (RT-PCR) is commonly used to detect the presence of COVID-19. Other techniques, such as recombinase polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), clustered regularly interspaced short palindromic repeats (CRISPR), and microfluidics, have allowed better disease diagnosis. Here, as part of the effort to expand screening capacity, we review advances and challenges in the rapid detection of COVID-19 by targeting nucleic acids, antigens, or antibodies. We also summarize potential treatments and vaccines against COVID-19 and discuss ongoing clinical trials of interventions to reduce viral progression.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.34133/2020/6925296
bibo:pmid	32607499
has license	cc-by
sha1sum (hex)	52ceadff361c2abd1065c4372719976a33f08922
schema:url	https://doi.org/10.34133/2020/6925296
resource representing a document's title	Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community
has PubMed Central identifier	PMC7315394
has PubMed identifier	32607499
schema:publication	Research (Wash D C)
resource representing a document's body	covid:52ceadff361c2abd1065c4372719976a33f08922#body_text
is schema:about of	named entity 'Detection' named entity 'Coronavirus' named entity 'COVID-19' named entity 'Ribavirin' named entity '2019-nCoV' named entity 'cytoplasm' named entity 'lung failure' named entity 'proteases' named entity 'proteases' named entity 'COVID' named entity 'virus' named entity 'RNA' named entity 'pancreas' named entity 'HIV' named entity 'RNA' named entity '2019-nCoV' named entity 'People's Republic of China' named entity 'RTP' named entity 'blood coagulation' named entity 'Wuhan' named entity 'zinc' named entity 'CRISPR' named entity 'immunoassays' named entity 'long-term' named entity 'arbidol' named entity 'COVID' named entity 'COVID-19' named entity 'TCM' named entity 'live attenuated vaccines' named entity 'proteases' named entity 'TCM' named entity 'COVID-19' named entity 'adenovirus' named entity 'acute respiratory distress syndrome' named entity 'drug discovery' named entity 'malnourishment' named entity 'clinical trial' named entity 'protein' named entity 'poly-A tail' named entity 'HTS' named entity 'MERS' named entity 'nucleocapsid' named entity 'pulmonary disorders' named entity 'chest CT' named entity 'antibody' named entity 'RNA' named entity 'structural proteins' named entity 'expression vector' named entity 'protein' named entity 'oxygen therapy' named entity '2019-nCoV' named entity 'TEM' named entity 'COVID' named entity 'reactive oxygen species' named entity 'Chloroquine' named entity 'SARS-CoV' named entity 'COVID-19' named entity 'nucleotides' named entity 'ivermectin' named entity 'host cells' named entity 'China' named entity '2019-nCoV' named entity 'noncovalent interactions' named entity 'quinine' named entity 'sensitivity, specificity' named entity 'ACE2' named entity 'nonstructural proteins' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software